Search research articles
Contact Us
Filters
Showing results (1-10 of 113) with videos related to
Page
of 12
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
January 19, 2012
Gaucher disease: hematologic and oncologic implications
Derralynn Hughes
Wiener Medizinische Wochenschrift (1946)
|
January 12, 2011
An overview on bone manifestations in Gaucher disease
Peter Mikosch, Derralynn Hughes
Neuro-Ophthalmology (Aeolus Press)
|
December 8, 2018
Photo Essay: Retinal Changes in Type 3 Gaucher Disease
Shweta Anand, Desmond Kidd, Derralynn Hughes
Drugs
|
April 12, 2025
Correction: Current and Emerging Therapies for Lysosomal Storage Disorders
Diego Agustín Abelleyra Lastoria, Sophie Keynes, Derralynn Hughes
Drugs
|
January 18, 2025
Current and Emerging Therapies for Lysosomal Storage Disorders
Diego Agustín Abelleyra Lastoria, Sophie Keynes, Derralynn Hughes
Ejhaem
|
February 26, 2024
The use of Ambroxol for the treatment of Gaucher disease: A systematic review
Diego Agustín Abelleyra Lastoria, Simranjeet Grewal, Derralynn Hughes
Acta Haematologica
|
May 22, 2008
The role of heparin in alleviating complement-mediated acute intravascular haemolysis
Deepak Mannari, Christine Liu, Derralynn Hughes, et al.
Frontiers in Cardiovascular Medicine
|
June 27, 2024
Inflammation in Fabry disease: stages, molecular pathways, and therapeutic implications
Hibba Kurdi, Lucia Lavalle, James C C Moon, et al.
Orphanet Journal of Rare Diseases
|
September 8, 2017
Fabry disease and incidence of cancer
Sarah Bird, Efthymios Hadjimichael, Atul Mehta, et al.
Oxford Medical Case Reports
|
April 8, 2020
Coombs-positive Paroxysmal Nocturnal Haemoglobinuria
Sabrina Kalam, Rupert Beale, Derralynn Hughes, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 113) with videos related to
Sort By:
Page
of 12
Clinical Advances in Hematology & Oncology : H&O
|
January 19, 2012
Gaucher disease: hematologic and oncologic implications
Derralynn Hughes
Wiener Medizinische Wochenschrift (1946)
|
January 12, 2011
An overview on bone manifestations in Gaucher disease
Peter Mikosch, Derralynn Hughes
Neuro-Ophthalmology (Aeolus Press)
|
December 8, 2018
Photo Essay: Retinal Changes in Type 3 Gaucher Disease
Shweta Anand, Desmond Kidd, Derralynn Hughes
Drugs
|
April 12, 2025
Correction: Current and Emerging Therapies for Lysosomal Storage Disorders
Diego Agustín Abelleyra Lastoria, Sophie Keynes, Derralynn Hughes
Drugs
|
January 18, 2025
Current and Emerging Therapies for Lysosomal Storage Disorders
Diego Agustín Abelleyra Lastoria, Sophie Keynes, Derralynn Hughes
Ejhaem
|
February 26, 2024
The use of Ambroxol for the treatment of Gaucher disease: A systematic review
Diego Agustín Abelleyra Lastoria, Simranjeet Grewal, Derralynn Hughes
Acta Haematologica
|
May 22, 2008
The role of heparin in alleviating complement-mediated acute intravascular haemolysis
Deepak Mannari, Christine Liu, Derralynn Hughes, et al.
Frontiers in Cardiovascular Medicine
|
June 27, 2024
Inflammation in Fabry disease: stages, molecular pathways, and therapeutic implications
Hibba Kurdi, Lucia Lavalle, James C C Moon, et al.
Orphanet Journal of Rare Diseases
|
September 8, 2017
Fabry disease and incidence of cancer
Sarah Bird, Efthymios Hadjimichael, Atul Mehta, et al.
Oxford Medical Case Reports
|
April 8, 2020
Coombs-positive Paroxysmal Nocturnal Haemoglobinuria
Sabrina Kalam, Rupert Beale, Derralynn Hughes, et al.
Page
of 12